Contact : +1 (888) 308-1808

/

October 2026

  • DM1 therapy shows promise over year of testing, trial data suggest

    Dyne Therapeutics‘ experimental therapy zeleciment basivarsen (z-basivarsen) may help improve multiple measures of physical function in people with myotonic dystrophy type 1 (DM1), new clinical trial data suggest. “What’s encouraging is that we observed improvements across multiple measures, including strength and functional assessments,” Doug Kerr, MD, PhD, chief medical officer at Dyne, said in an…

    Know More

  • Becker Education and Engagement Day 2026: Building Knowledge, Connection, and Community

    A guest blog authored by Nevin Steiner, PPMD’s Adult Advisory Committee (PAAC) Becker Officer Living with Becker muscular dystrophy looks different for everyone. Our experiences, symptoms, care needs, and goals may vary, but we share a common need for information, support, and a community that understands. That’s what makes Becker Education and Engagement Day (BEED)…

    Know More

  • Fellowship Update: Universal Antibody Screening Test for AAV Gene Therapy

    As gene therapy research continues to advance, understanding who may be eligible for a particular treatment remains an important challenge for the Duchenne and Becker community. PPMD is committed to supporting research that addresses these challenges and helps move the field forward. Today, we’re sharing an update on a research project funded through PPMD’s Gene…

    Know More

  • Quest Podcast: Nothing Left to Prove: A Conversation with Kiersten Riggs

    In this episode of the Quest Podcast, we chat with Kiersten Riggs, a 24-year-old rare disease advocate from Tulsa, Oklahoma, who was a varsity cheerleader when her family first heard the words Friedreich’s ataxia (FA). Kiersten opens up about being diagnosed alongside her older sister, the four years she spent hiding from the FA community…

    Know More

  • Pursuing meaningful work while living with Duchenne muscular dystrophy

    Last Friday, my girlfriend, Amanda Yip, and I celebrated the second year of Rebirth Ensemble, the disability-led creative business we founded in Singapore in October 2024. We began with an ambition: to make art more accessible. Now, we’re exploring creative storytelling, multisensory art, and accessibility consultancy. Yet the biggest change hasn’t been our business path;…

    Know More

  • Muscle Regeneration Remains a Hot Topic at MDA Clinical & Scientific Conference

    Every March, the leading clinicians and researchers in the field of neuromuscular disease join industry partners, advocacy organizations, and community members at the MDA Clinical & Scientific Conference to share their expertise on the exploration of new treatments, groundbreaking research, and clinical accomplishments. The conversations and presentations that occur at conference on topics related to…

    Know More

  • Bionews survey highlights key drivers of mental health distress in MD

    Mental health problems such as anxiety and depression are common for people with muscular dystrophy, affecting most individuals in the community, according to a new survey. The survey was carried out by Bionews, the parent company of Muscular Dystrophy News. Survey results indicate that loneliness, regret, and uncertainty play key roles in driving mental health…

    Know More

  • Sam’s Night Celebrates 21 Years of Fighting to End Duchenne, Raises $1.7 Million for PPMD

    The Killian family of Rockwall, Texas, is celebrating another successful year of Sam’s Night, their annual fundraiser benefiting Parent Project Muscular Dystrophy (PPMD), the leading U.S. nonprofit driving Duchenne and Becker muscular dystrophy care, research, and advocacy efforts. On Thursday, October 15, the Killian family welcomed friends, family, and supporters to Victory Social for the…

    Know More

  • Scientists discover how exercise reverses muscle aging

    Scientists have uncovered a hidden biological mechanism that helps explain how exercise can reverse some of the damage caused by muscle aging. The key is a gene called DEAF1, which becomes overactive with age and interferes with the muscles’ ability to clear damaged proteins and repair themselves. Exercise can help restore this balance, allowing older…

    Know More

  • Six Ways You Can Make a Difference

    MDA’s mission to empower people living with neuromuscular disease to live longer, more independent lives is pursued through a variety of influential and meaningful endeavors. From accelerating research and advancing care to advocating support and providing opportunities for members of our community to connect, grow, and shine – there are a multitude of different ways…

    Know More